Physician
Baker, Brenda
Baker, Brenda was paid $4.37M by Medicaid between Jan 2018 and Dec 2024, across 21 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 37% of everything it billed.
33Billing provider infoBAKER, BRENDA
NEON, KY 41840
NEON, KY 41840
33aNPI1013088947assigned 11/13/2006
33bProvider typeFamily Medicine Physician
28Total paid$4.37M
24GClaims85,509
24DCodes billed21
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Kentucky
Rank by total paid#19 of 352
Median peer was paid$90K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,524 | $186K | |
| 2019 | 7,027 | $274K | |
| 2020 | 8,179 | $328K | |
| 2021 | 12,388 | $495K | |
| 2022 | 17,180 | $718K | |
| 2023 | 17,377 | $1.19M | |
| 2024incomplete | 16,834 | $1.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 37% | 36,112 | 16,750 | $1.59M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 40,194 | 19,634 | $1.45M |
| T2023 | Targeted case management; per month | 25% | 2,154 | 2,131 | $1.09M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.7% | 1,517 | 1,260 | $73K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.3% | 582 | 539 | $57K |
| 99205 | Prolong outpt/office vis | <1% | 343 | 325 | $43K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,117 | 688 | $19K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 819 | 644 | $19K |
| 80305 | <1% | 1,071 | 616 | $7K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 387 | 366 | $5K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 76 | 48 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 57 | 54 | $2K |
9 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 152 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 144 | $2K |
| 99354 | <1% | 48 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 122 | $1K |
| 81003 | <1% | 437 | $157.79 | |
| 99408 | <1% | 68 | $125.88 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 23 | $113.71 |
| 99406 | <1% | 12 | $45.36 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 74 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.